For the two models created, 42 patients we used a training cohort of 30 patients with 12 subjects as the testing cohort.</p
Abstract Dose‐ranging studies are a crucial part of the phase II drug development process. They comp...
PURPOSE In drug safety and effectiveness studies based on secondary data, the choice of an approp...
<p>Cohort I: Percent of Targeted Dose (relative to targeted dose at start of treatment) for patients...
<p>*NA = not applicable</p><p>** Administered dose / planned dose according to the protocol per coho...
Background Randomized controlled trials (RCTs) are often complex and expensive to perform. Less than...
Collection of accurate exposure information on study participants is a major objective of all epidem...
Background Randomized controlled trials (RCTs) are often complex and expensive to perform. Less than...
Background: Exposure definitions vary across pharmacoepidemiological studies. As different definitio...
In pharmaco-epidemiology, the use of drugs is the determinant of interest when studying exposure-out...
<p>(A) Exposure, immunization and antagonist schedule. Groups: (a) vehicle control, (b) OVA, (c) FA,...
<p>Participant disposition by randomization group, showing modified intent-to-treat (mITT) and modif...
To describe the characteristics of randomized controlled clinical trials (RCT) on cancer drugs condu...
Flow chart describing handling and anesthesia schedule for the 5 groups of rats tested in Figs 2–5. ...
Pre-emptive pharmacogenomic (PGx) testing of a panel of genes may be easier to implement and more co...
<p>22 patients consented to participate in the study. Two patients declined repeat testing and were ...
Abstract Dose‐ranging studies are a crucial part of the phase II drug development process. They comp...
PURPOSE In drug safety and effectiveness studies based on secondary data, the choice of an approp...
<p>Cohort I: Percent of Targeted Dose (relative to targeted dose at start of treatment) for patients...
<p>*NA = not applicable</p><p>** Administered dose / planned dose according to the protocol per coho...
Background Randomized controlled trials (RCTs) are often complex and expensive to perform. Less than...
Collection of accurate exposure information on study participants is a major objective of all epidem...
Background Randomized controlled trials (RCTs) are often complex and expensive to perform. Less than...
Background: Exposure definitions vary across pharmacoepidemiological studies. As different definitio...
In pharmaco-epidemiology, the use of drugs is the determinant of interest when studying exposure-out...
<p>(A) Exposure, immunization and antagonist schedule. Groups: (a) vehicle control, (b) OVA, (c) FA,...
<p>Participant disposition by randomization group, showing modified intent-to-treat (mITT) and modif...
To describe the characteristics of randomized controlled clinical trials (RCT) on cancer drugs condu...
Flow chart describing handling and anesthesia schedule for the 5 groups of rats tested in Figs 2–5. ...
Pre-emptive pharmacogenomic (PGx) testing of a panel of genes may be easier to implement and more co...
<p>22 patients consented to participate in the study. Two patients declined repeat testing and were ...
Abstract Dose‐ranging studies are a crucial part of the phase II drug development process. They comp...
PURPOSE In drug safety and effectiveness studies based on secondary data, the choice of an approp...
<p>Cohort I: Percent of Targeted Dose (relative to targeted dose at start of treatment) for patients...
DOI
Add to ORKG